Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion type Assertion NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_head.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion description "[To verify whether enhanced substrate-level phosphorylation increases viability and adenosine 5'-triphosphate (ATP) content of cells with neuropathy, ataxia, and retinitis pigmentosa/maternally inherited Leigh syndrome (NARP/MILS) mitochondrial DNA mutations and ATP synthase dysfunction.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_provenance.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion evidence source_evidence_literature NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_provenance.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion SIO_000772 19667215 NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_provenance.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion wasDerivedFrom befree-20150227 NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_provenance.
- NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_assertion wasGeneratedBy ECO_0000203 NP598303.RA_DPqUIJEeQUp0FU5vVipJmDsk8q9rfPJ224eDNsmj1A130_provenance.